Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics.

Détails

ID Serval
serval:BIB_C1011F8E740B
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics.
Périodique
European Journal of Cardiovascular Prevention and Rehabilitation
Auteur(s)
Romanens M., Ackermann F., Spence J.D., Darioli R., Rodondi N., Corti R., Noll G., Schwenkglenks M., Pencina M.
ISSN
1741-8275[electronic], 1741-8267[linking]
Statut éditorial
Publié
Date de publication
2010
Peer-reviewed
Oui
Volume
17
Numéro
1
Pages
18-23
Langue
anglais
Résumé
Cardiovascular risk assessment might be improved with the addition of emerging, new tests derived from atherosclerosis imaging, laboratory tests or functional tests. This article reviews relative risk, odds ratios, receiver-operating curves, posttest risk calculations based on likelihood ratios, the net reclassification improvement and integrated discrimination. This serves to determine whether a new test has an added clinical value on top of conventional risk testing and how this can be verified statistically. Two clinically meaningful examples serve to illustrate novel approaches. This work serves as a review and basic work for the development of new guidelines on cardiovascular risk prediction, taking into account emerging tests, to be proposed by members of the 'Taskforce on Vascular Risk Prediction' under the auspices of the Working Group 'Swiss Atherosclerosis' of the Swiss Society of Cardiology in the future.
Mots-clé
Biological Markers/blood, Cardiovascular Diseases/diagnosis, Cardiovascular Diseases/etiology, Carotid Artery Diseases/complications, Carotid Artery Diseases/pathology, Cholesterol, HDL/blood, Cost-Benefit Analysis, Discriminant Analysis, Dyslipidemias/blood, Dyslipidemias/complications, Evidence-Based Medicine, Health Status Indicators, Humans, Likelihood Functions, Models, Statistical, Odds Ratio, Practice Guidelines as Topic, Predictive Value of Tests, Prognosis, ROC Curve, Reproducibility of Results, Risk Assessment, Risk Factors
Pubmed
Web of science
Création de la notice
24/12/2009 12:13
Dernière modification de la notice
03/03/2018 21:07
Données d'usage